Restless Nights Predict Alzheimer’s?

Researchers find that disrupted sleep-wake cycles could reflect or even contribute to the neurodegenerative disease.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Amyloid plaque formations in the brain of a deceased Alzheimer’s patient. Wikimedia Commons, JensflorianDisturbed sleeping patterns could be a marker for the onset of Alzheimer’s disease, according to research presented this week (October 17) at the annual meeting of the Society for Neuroscience in New Orleans, Louisiana. The findings could lead to new ways to diagnose the condition and facilitate early identification of people at risk.

Alzheimer’s patients often experience changes to their sleep-wake cycles during the early stages of the disease. To find out if sleep disruption is linked to the development of Alzheimer’s, neuropsychologists at Dalhousie University in Halifax, Canada, used sleep quality data from a survey of 14,600 healthy people age 50 or older to produce what they called a sleep disturbance index. They found that people who reported trouble with sleep-wake cycles—particularly disturbed sleep and tiredness during the day—were more likely to be diagnosed with Alzheimer’s within the next 2 years. Moreover, the severity of symptoms correlated with the severity of sleep disruption before diagnosis.

The results suggest that disturbed sleep could be an early marker for the brain changes that occur as the disease progresses—namely the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies